Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3657_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Preface
- •Contents
- •Contributors
- •Endovascular Aneurysm Repair
- •Clinical Applications
- •Aortic Procedures Planning
- •Performance Assessment
- •Future Prospects
- •References
- •References
- •Introduction
- •Medical Error
- •Traditional Training
- •Animal Simulation Labs
- •Virtual Reality Simulation
- •3: Radiation Safety
- •Introduction
- •Basic Radiation Physics Units
- •Personnel Dose Limits
- •Pregnant Personnel
- •References
- •4: Tools of the Trade
- •Needles, Catheters, and Wires
- •Vascular Access
- •Double Wall
- •Single Wall
- •Advantages/Disadvantages
- •Nonvascular Needles (Table 4.1)
- •Guidewires
- •Curved
- •Straight/Angled
- •Stiffness
- •Flexibility
- •Coating
- •Torqueability
- •Opacity
- •Catheters
- •Flush Catheters
- •Visceral Catheters
- •Multipurpose Catheters
- •Cerebral Catheters
- •Guiding Catheters
- •Microcatheters
- •Vascular Sheaths
- •Vessel Dilators
- •Accessories
- •Embolic Agents
- •Temporary Agents
- •Permanent Agents
- •Pushable Coils
- •Detachable Coils
- •Coiling Techniques (Fig. 4.48)
- •Vascular Plugs
- •Particulates
- •Liquid Embolics
- •Fogarty Balloons
- •Angioplasty Balloons
- •Drug-Coated Balloons
- •Vascular Stents
- •Balloon Expandable Stents
- •Self-Expandable Stents
- •Specialty Stents
- •References
- •Consults
- •Pre-procedure Evaluation
- •Consent
- •Code Status
- •Laboratory Testing
- •Antibiotic Prophylaxis
- •Anticoagulation
- •Antihypertensives
- •Contrast Allergy Prophylaxis
- •Procedure Plan
- •Post-procedure Management
- •Hospital Admission
- •Discharge
- •Follow-up Visits
- •IR Clinic
- •Conclusion
- •References
- •6: The IR Road Map: Vascular Anatomy Overview
- •Introduction
- •Imaging Modalities
- •Ultrasound
- •Computed Tomography
- •Magnetic Resonance Imaging
- •Cross-Sectional Anatomy
- •Chest
- •Segmental Lung Anatomy
- •Mediastinum
- •Pulmonary Arteries
- •Pulmonary Veins
- •Bronchial Arteries
- •Liver
- •Arterial Access
- •Double-Wall Technique
- •Common Femoral Artery Access
- •Kidneys
- •Ureters
- •Bladder
- •Uterus
- •References
- •Alternative Arterial Access Sites
- •Venous Access
- •Manual Compression
- •Closure Devices
- •Compression Devices
- •Topical Agents
- •Invasive Devices
- •References
- •9: Central Venous Access
- •Pathophysiology
- •Non-tunneled Central Catheters (NTCCs)
- •Tunneled Central Catheters (TCCs)
- •Implantable Ports
- •Peripherally Inserted Central Catheters (PICCs)
- •Clinical Indication
- •Conventional Therapy
- •Non-tunneled Central Catheters
- •Tunneled Central Catheters
- •Ports
- •PICCs
- •Interventional Therapy
- •Ports
- •PICCs
- •Pre-procedural Prep
- •History
- •Physical Exam
- •Imaging
- •Complex Venous Access
- •Post-procedural Management
- •Complications
- •Acute Complications
- •Long-Term Complications
- •Device Removal
- •Tunneled Catheter Removal
- •Port Removal
- •References
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •References
- •11: IVC Filters
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •IVC Filter Placement
- •VTE Prevention
- •Preprocedural Preparation
- •Complication
- •Access Site
- •Device-Related
- •Postprocedural Management
- •IVC Filter Retrieval
- •Advanced IVC Filter Retrieval Techniques
- •Conclusion
- •References
- •Pathophysiology
- •Arteriovenous Fistula
- •Arteriovenous Graft
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •AVG Angioplasty
- •AVF Angioplasty
- •References
- •13: Pelvic Congestion Syndrome
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •References
- •14: Varicocele
- •Pathophysiology
- •Conventional Therapy
- •Interventional Therapy
- •References
- •15: Varicose Veins
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •References
- •16: Vascular Malformations
- •Pathophysiology
- •Hemangiomas
- •Vascular Malformations
- •Arteriovenous Malformations (High Flow)
- •Venous Malformations (Low Flow)
- •Lymphatic Malformations
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •High-Flow AVMs
- •Low-Flow Venous Malformations
- •Klippel-Trenaunay Syndrome
- •Lymphatic Malformations
- •References
- •Pathophysiology
- •Abdominal Aortic Aneurysm (AAA)
- •Thoracic Aortic Aneurysm (TAA)
- •Clinical Indication
- •Abdominal Aortic Aneurysm
- •Thoracic Aortic Aneurysm
- •Conventional Therapy
- •Abdominal Aortic Aneurysm
- •Thoracic Aortic Aneurysm
- •Interventional Therapy
- •Abdominal Aortic Aneurysm
- •Thoracic Aortic Aneurysm
- •Common Complications
- •Access
- •Contrast Nephropathy
- •Spinal Cord Ischemia
- •Postoperative Monitoring
- •References
- •18: Aortic Dissection
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Preprocedure Work-Up
- •Post-procedural Management
- •References
- •19: Endoleak
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Type II Endoleaks
- •Type III Endoleaks
- •Type IV Endoleaks
- •Type V Endoleaks
- •References
- •20: Traumatic Aortic Injury
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Pre-procedural Prep
- •Pre-procedural Imaging
- •Post-procedural Management
- •Post-procedural Imaging
- •References
- •21: Bronchial Artery Embolization
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Outcomes
- •References
- •Pathophysiology
- •Pulmonary Arteriovenous Malformation
- •Pulmonary Artery Pseudoaneurysm
- •Clinical Indication
- •Pulmonary Arteriovenous Malformation
- •Pulmonary Artery Pseudoaneurysm
- •Conventional Therapy
- •Pulmonary Arteriovenous Malformation
- •Pulmonary Artery Pseudoaneurysm
- •Interventional Therapy
- •Pulmonary Arteriovenous Malformation
- •Pulmonary Artery Pseudoaneurysm
- •References
- •23: Lymphatic Interventions
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Pedal Lymphangiography (PL)
- •Intranodal Lymphangiography (IL)
- •Dynamic Contrast Enhanced MR Lymphangiography (DCMRL)
- •Thoracic Duct Embolization
- •Plastic Bronchitis
- •References
- •24: Mesenteric Ischemia
- •Pathophysiology
- •Acute Mesenteric Ischemia
- •Chronic Mesenteric Ischemia
- •Clinical Indication
- •Acute Mesenteric Ischemia
- •Arterial Occlusive Disease
- •Nonocclusive Mesenteric Ischemia (NOMI)
- •Portomesenteric Vein Thrombosis
- •Chronic Mesenteric Ischemia
- •Conventional Therapy
- •Acute Mesenteric Ischemia
- •Arterial Occlusive Disease
- •Nonocclusive Mesenteric Ischemia (NOMI)
- •Portomesenteric Vein Thrombosis
- •Chronic Mesenteric Ischemia
- •Interventional Therapy
- •Acute Mesenteric Ischemia
- •Chronic Mesenteric Ischemia
- •References
- •25: Visceral Aneurysms
- •Pathophysiology
- •Visceral Artery True Aneurysms (VATAs)
- •Visceral Artery Pseudoaneurysm (VAPA)
- •Clinical Indication
- •VATA
- •VAPA
- •Conventional Therapy
- •Interventional Therapy
- •Splenic Artery Aneurysms
- •Renal Artery Aneurysms
- •Hepatic Artery Aneurysms
- •Celiac Artery Aneurysms
- •Complications
- •Splenic Aneurysm
- •Renal Aneurysm
- •Hepatic Aneurysm
- •References
- •26: Renal Artery Stenosis
- •Pathophysiology
- •Clinical Indications
- •Conventional Therapy
- •Interventional Therapy
- •Post-procedural Care
- •Conclusion
- •References
- •27: GI Bleeding
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Complications
- •References
- •28: Uterine Artery Embolization
- •Pathophysiology
- •Fibroids
- •Adenomyosis
- •Postpartum Hemorrhage
- •Clinical Indication
- •Conventional Therapy
- •Fibroids
- •Adenomyosis
- •Postpartum Hemorrhage
- •Interventional Therapy
- •Fibroids
- •Adenomyosis
- •Postpartum Hemorrhage
- •AV Fistula
- •References
- •29: Prostate Artery Embolization
- •Pathophysiology
- •Benign Prostatic Hyperplasia
- •Prostate Cancer/Hematuria
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •References
- •30: Aortoiliac Disease
- •Pathophysiology
- •Blue Toe Syndrome
- •Leriche Syndrome
- •Fibromuscular Dysplasia
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Abdominal Aorta
- •Aortic Bifurcation
- •Common Iliac Artery
- •External Iliac Artery
- •Internal Iliac Artery
- •Blue Toe Syndrome
- •References
- •31: Infrainguinal Disease
- •Pathophysiology
- •Claudication (Rutherford Categories 1–3)
- •Critical Limb Ischemia: Rest Pain (Rutherford Category 4)
- •Critical Limb Ischemia: Skin Lesions (Rutherford Categories 5–6)
- •Acute Limb Ischemia
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Percutaneous Transluminal Angioplasty
- •Stents
- •Acute Limb Ischemia
- •References
- •Pathophysiology
- •Spleen
- •Liver
- •Kidney
- •Clinical Indication
- •Spleen
- •Liver
- •Kidney
- •Conventional Therapy
- •Spleen
- •Liver
- •Kidney
- •Interventional Therapy
- •Spleen
- •Pre-procedure
- •Post-procedure
- •Liver
- •Pre-procedure
- •Post-procedure
- •Kidney
- •Pre-procedure
- •Post-procedure
- •References
- •Pathophysiology
- •Pelvic Fractures
- •Extremity Fractures
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •References
- •34: Transarterial Chemoembolization
- •Pathophysiology
- •Clinical Indications
- •Conventional Therapy
- •Medical Management
- •Surgical Management
- •Interventional Therapy
- •Post-procedure
- •References
- •35: Transarterial Radioembolization (TARE)
- •Introduction
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Primary Liver Cancers
- •Hepatic Metastatic Disease
- •References
- •36: Liver Ablation
- •Pathophysiology
- •Liver Cancer
- •Liver Metastases
- •Liver Cysts
- •Clinical Indication
- •Conventional Therapy
- •Liver Cancer
- •Liver Metastases
- •Liver Cysts
- •Interventional Therapy
- •References
- •Pathophysiology
- •Lung Cancer
- •Renal Cell Carcinoma
- •Bone Lesions
- •Clinical Indication
- •Lung Cancer
- •Kidney Cancer
- •Bone Lesions
- •Conventional Therapy
- •Lung Cancer
- •Kidney Cancer
- •Bone Lesions
- •Interventional Therapy
- •Radiofrequency Ablation (RFA)
- •Microwave Ablation (MWA)
- •Cryoablation
- •Irreversible Electroporation (IRE)
- •Lung Cancer
- •Kidney Cancer
- •Bone Lesions
- •References
- •Pathophysiology
- •Conventional Therapy
- •Ascites
- •Varices
- •Interventional Therapy
- •References
- •Pathophysiology
- •Etiology
- •Clinical Indication
- •Conventional Therapy
- •Medical Management
- •Surgical Management
- •Interventional Therapy
- •Post-procedural Management
- •Complications
- •References
- •40: Biliary Drainage
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Conclusion
- •References
- •41: Biopsy Techniques
- •Introduction
- •Clinical Indication
- •Interventional Therapy
- •Needle Selection
- •Biopsy Techniques
- •References
- •Introduction
- •Pathophysiology
- •Ascites
- •Clinical Indication
- •Ascites
- •Conventional Therapy
- •Ascites
- •Interventional Therapy
- •Ascites
- •References
- •43: Obstructive Uropathy
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Urolithiasis
- •Infection
- •Urothelial Carcinoma
- •Neurogenic Bladder
- •Interventional Therapy
- •References
- •Pathophysiology
- •Clinical Indications
- •Percutaneous Radiologic Gastrojejunostomy (PRGJ) Tube
- •Percutaneous Jejunostomy (PJ) Tube
- •Conventional Therapy
- •Interventional Therapy
- •Percutaneous Radiologic Gastrostomy (PRG)
- •Post-procedural Management
- •Percutaneous Radiologic Gastrojejunostomy (PRGJ)
- •Percutaneous Jejunostomy (PJ)
- •References
- •45: Stroke
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Complications
- •Post-procedure Management
- •References
- •46: Cerebral Angiography: Aneurysms
- •Pathophysiology
- •Clinical Indication
- •Conventional Therapy
- •Interventional Therapy
- •Pre-procedural Preparation
- •Post-procedural Management
- •Complications
- •References

TASC A lesions:
both common iliac arteries (CIA) or short
segment stenosis (<3 cm) that involve one
or both external iliac arteries (CIA).
TASC B lesions:
the infrarenal aorta, unilateral CIA occlusion,
single or multiple stenosis totaling 3-10 cm
involving the EIA but not extending into
the CFA, unilateral EIA occlusion not
involving the origin of the internal iliac or CFA.
TASC C lesions:
bilateral EIA stenosis 3-10 cm long not
extending into the CFA, unilateral EIA
stenosis extending into the CFA, unilateral
EIA occlusion that involves the origins of
the hypogastric artery and/or CFA, heavily
calcified unilateral EIA occlusion with or
without involvement of origins of the
internal iliac and/or CFA.
TASC D lesion:
diffuse disease involving the aorta and both iliac
arteries requiring treatment, diffuse multiple
stenosis involving the unilateral CIA, EIA,
CFA; unilateral occlusions of both CIA and
EIA; bilateral occlusions of EIA, iliac stenosis
in patients with abdominal aortic aneurysm
(AAA) requiring treatment and not amenable
to endograft placement or other lesions
requiring open aortic or iliac surgery.
30 Aortoiliac Disease
335
bypass range from aorta to femoral, aorta to bifemoral,
aorta to iliac, femoral to femoral, and axillary to femoral
artery bypasses. An aortic bifurcation bypass has a good
5-year patency rate of 90%. Extra-anatomic bypass grafts
have poorer outcomes with 5-year patency of 51% and
75% for axillary-unifemoral and axillary-bifemoral
bypass grafts, respectively [9].
In 2000, the TransAtlantic Inter-Society Consensus
(TASC) guidelines were published in a document that organized aortic and iliac lesions based on anatomic distribution
stenosis involving one or
short (<3 cm) stenosis of
and morphology. They were initially published to denote
which lesions were more suitable for endovascular therapy
and which ones were better suited to surgical repair. In 2007,
the guidelines were revised to expand the role of endovascular therapy (Fig.30.2) [10].
Although the TASC guidelines were developed to help
guide endovascular versus surgical therapy, they are seldom
used for clinical decision-making. As technology improves
and better devices facilitate percutaneous revascularization,
most practitioners espouse an endovascular-rst approach.
Fig. 30.2 The 2007 TransAtlantic Inter-Society Consensus (TASC) guidelines
bilateral CIA occlusions,
infra-renal aortoiliac occlusion,

336
A. B. Bhatt and J. F. Benenati
Today, the TASC guidelines are typically used for research
purposes and serve as a useful anatomic descriptor of disease
distribution.
Interventional Therapy
The approach to aortic and iliac lesions depends largely on
the distribution of disease. For example, a patient who has an
ostial common iliac artery stenosis will have a different
treatment strategy than a patient who has a mid common
iliac artery stenosis. It is helpful to group lesions according
to their anatomic location as follows: isolated abdominal
aorta stenosis, aortic bifurcation, common iliac artery, and
external iliac artery.
Abdominal Aorta
Aortic occlusive disease typically involves the infrarenal
Key Point
balloon-expandable stents are commonly used to prevent
ow abnormalities at the aortic bifurcation. In patients that
have an associated abdominal aortic aneurysm, care should
be taken to not place the iliac stents too proximally within
the abdominal aorta because this may preclude future endovascular repair of the abdominal aortic aneurysm.
Common Iliac Artery
Lesions in the non-ostial segments of the common iliac artery
are typically treated with primary stenting. Stent types include
balloon-expandable, self-expanding, bare metal, and covered
stents. Within the common iliac artery, balloon- expandable
stents are usually preferred because they have higher hoop
strength than self-expanding stents. The large- scale, multicenter, multinational prospective BRAVISSIMO trial demonstrated a 12-month primary patency rate of 93% in patients
with iliac lesions that underwent primary stenting, noting that
this was comparable to open surgical bypass [11].
External Iliac Artery
• Endovascular treatment is based on anatomic
location:
• Abdominal aorta=angioplasty + uncovered stent
• Aortic bifurcation=kissing iliac stents
• Common iliac artery=balloon-expandable stent
• External iliac artery=self-expandable stents
abdominal aorta, much like aneurysmal disease. It usually
occurs below the origin of the inferior mesenteric artery.
Unlike aneurysmal disease, percutaneous therapy involves
angioplasty with placement of uncovered stents. Typically,
balloon-expandable stents are chosen because they provide
greater radial force. They can also be overdilated to achieve
a larger diameter (Fig.30.3).
Aortic Bifurcation
Atherosclerotic lesions that involve the aortic bifurcation
warrant special consideration. When a stenotic lesion
involves the origin of the common iliac artery and distal
abdominal aorta, kissing iliac stents are typically required
(Fig.30.4). Angioplasty and stenting of a lesion in this location in isolation without treating the contralateral side may
cause plaque shifting/embolization and luminal stenosis of
the untreated contralateral common iliac artery. Covered
Lesions within the external iliac artery are also typically
treated with primary stenting. Unlike the common iliac
artery, the external iliac arteries are more tortuous and are
subject to more external forces. As a result, self-expanding
stents are preferred in this location.
Internal Iliac Artery
The internal iliac arteries are infrequently treated in isolation.
They are, however, an important consideration when treating
common and extra iliac lesions. One retrospective evaluation
found that even when bare metal stents are placed across the
origin of the hypogastric arteries, although immediate occlusion is rare, their long-term patency is reduced [12]. Typically,
as long as one hypogastric artery remains patent, there is
enough cross lling within the pelvis to prevent signicant
symptomology. If both are occluded, especially acutely, the
patient may experience buttock claudication, impotence, and,
rarely, pelvic visceral ischemia.
Pre-procedurally, the patient should be medically optimized for revascularization. All patients that can tolerate
aspirin therapy should be started on a daily baby aspirin.
Based on the HOPE and EUROPA trials, all patients with
PAD should be started on an ACE inhibitor, irrespective of
their blood pressure because ACE inhibitors have been
shown to decrease the incidence of stroke and MI, even in
PAD patients that are otherwise normotensive. Statin therapy

30 Aortoiliac Disease
337
Fig. 30.3 (a) Patient with Rutherford 3 claudication found to have aor-
tic stenosis. This is a normal segment of the patient’s aorta distal to the
renal arteries and the inferior mesenteric artery which is key to safely
treating this patient with angioplasty and stent placement. (b) Slightly
inferiorly, there is a segment of stenotic infrarenal abdominal aorta
(arrow), across which there was a 70mmHg gradient at rest. (c) During
treatment, bilateral common femoral arterial accesses are obtained.
Through the left groin, a multi-sidehole catheter (arrow) was advanced
to facilitate imaging. Through the right groin, a sheath is advanced
across the lesion (arrowhead). This sheath will facilitate safe and precise positioning of a balloon-expandable stent. (d) The sheath is
should also be started on all patients with PAD. Routine labs
should be checked including a CBC and BMP. In patients
with chronic kidney disease, IV hydration can help reduce
the risk of contrast-induced nephropathy.
Before the procedure, it is also critical to review the
patient’s noninvasive evaluation including available crosssectional imaging and correlate the ndings with the patient’s
retracted (arrowhead) allowing the balloon-expandable stent to be
deployed. As the balloon is inated to deploy the stent (dashed arrow),
the multi-sidehole catheter (solid arrow) can be intermittently used for
imaging to ensure appropriate deployment of the stent. As the stent is
deployed, the catheter is retracted prior to full expansion of the stent. (e)
Post-stenting angiogram shows appropriate positioning of the stent
below the origin of the inferior mesenteric artery (solid arrow) and
above the origin of an inferior accessory right renal artery (dashed
arrow). Post-procedure pressure measurements revealed no signicant
gradient, with resolution of the pre-procedure 70mmHg gradient across
the stenotic segment of the aorta
symptomatology. Pre-procedure CTA is very helpful for
planning the treatment approach in aortoiliac disease. Not all
stenoses warrant treatment, and oftentimes, intra-procedural
digital subtraction angiography, intravascular ultrasound,
and pressure measurements will reveal lesions that may not
be clinically signicant. Depending on the location of the
lesion, the steps of the procedure and devices used will vary.

338
A. B. Bhatt and J. F. Benenati
Fig. 30.4 (a) Patient was a Rutherford 3 claudicant with evidence of
inow disease on her noninvasive testing. Her initial angiogram
revealed bilateral ostial common iliac artery stenoses (arrows) which
had a 40mmHg gradient across them following the administration of
intra-arterial nitroglycerine. (b) Access is gained through both common
femoral arteries. Because of their location, balloon-expanding stents
were used for treatment. Sheaths were advanced centrally across both
stenoses. Image shows left common femoral artery sheath is across the
stenosis (arrow). Access was then obtained in the right CFA through
which a sheath was placed (dashed arrow). Following access, it was
subsequently advanced centrally like the left CFA sheath. (c) Both
stents were simultaneously deployed in a kissing fashion. (d) Postprocedure angiogram demonstrates successful treatment of both lesions
with no pressure gradient across the stented segments

30 Aortoiliac Disease
339
The How To
1. Most aortoiliac interventions will require a single
common femoral artery access, but many will
require bilateral groin access and perhaps even
radial or brachial artery access. Treating lesions
isolated to the abdominal aorta typically requires
two accesses, one to place a catheter for angiography and the other through which to deploy the
stent. Having an imaging catheter facilitates precise stent deployment because it allows for realtime imaging as the stent is being deployed.
Lesions of the aortic bifurcation require bilateral
groin access for kissing stent placement. Lesions
of the mid and distal common iliac artery are best
treated with ipsilateral access, whereas lesions in
the external iliac artery are best treated by accessing the contralateral groin. Access is obtained
using the typical Seldinger technique, and a short
sidearm sheath is placed (refer to Chap. 8 for more
information).
2. Once access is obtained, a pigtail or other multisidehole catheter will be advanced into the abdominal aorta, and a pelvic angiogram will be
performed in the anteroposterior as well as bilateral oblique projections. Imaging in these three
projections allows accurate delineation of anatomy
by isolating each segment of the abdominal aorta
and iliac vessels. The lesions of interest should be
evaluated for severity, length of stenosis or occlusion, and the size of the adjacent normal vessel.
This allows for accurate sizing of the angioplasty
balloons and stents. The oblique views also allow
the operator to evaluate the patency of both internal iliac arteries in case one needs to be covered
by a stent.
3. Wire access is then obtained across the lesion of
interest. A common method by which to do this is
catheter. If an acute occlusion is present and the
limb is viable, the occlusion will typically be treated
by placing a thrombolysis catheter and administer-
acute thrombus and can unmask any culprit lesions
responsible for the acute occlusion.
4.
question, trans-stenotic pressure measurements
are obtained. A pressure gradient of greater than
rial nitroglycerine can be administered to mimic
exercise. In this setting, a gradient of greater than
9].
5. If a severe stenosis is present, balloon angioplasty
may be required to facilitate passage of catheters
and sheaths. Angiography should be performed
after each angioplasty to monitor for complications including rupture. If a rupture is suspected,
tamponade the rupture, and a covered stent should
be deployed.
6. If a balloon-expandable stent is to be used, an
appropriately sized sheath must be advanced past
the lesion through which an undeployed stent can
safely be advanced. Once the stent is in position,
it is unsheathed (the sheath is retracted proximal
to deploy the stent. If a balloon-expandable stent
is advanced through a stenosis without the use of
a sheath, the stent can catch on plaque and
become dislodged from the balloon. Using a
the stent once it is in position help prevent this
complication.
7. If a self-expanding stent is to be used, it can be
advanced over the wire without the use of a long
delivery sheath. When they are deployed, the leading
end of the stent should always be deployed slightly
distal to the intended landing zone. As the distal
end of the stent is being deployed, the entire stent
can be slightly retracted but never advanced [13].
8. When kissing stents are deployed at the aortic
bifurcation, sheaths are advanced into the abdominal aorta from each common femoral artery access
to facilitate delivery of balloon-expandable stents.
Once the sheaths are retracted, the balloonexpandable stents are deployed simultaneously so
that each stent ultimately has the same diameter.
9. Once the stent is deployed, a post-deployment
angiogram is performed. If needed, balloonexpandable stents can be further dilated using a
bigger balloon, but this luminal gain comes at the
expense of foreshortening the stent. Selfexpanding stents on the other hand cannot be
overdilated, so appropriate sizing is critical.
Post-dilatation with a non-compliant balloon
may allow for more uniform expansion of the
stent.
10.
should be performed to ensure that the target
lesion was adequately treated. The angiogram
-
will also evaluate for iatrogenic complications
including dissection or rupture. Post-procedure
trans-stenotic pressure measurements can also

340
A. B. Bhatt and J. F. Benenati
Following each intervention, patients should again be
counseled on managing modiable risk factors. Following
stenting, many providers will start patients on a daily baby
aspirin if the patient is not already on one. Plavix is typically
not used when the aorta or relatively large iliac arteries are
stented. If a drugeluting stent is used however, dual antiplatelet therapy should be administered for at least 3 months.
Patients with CKD should again receive intravenous hydration following contrast administration. A postprocedure
duplex and pulse volume recordings can be ordered to determine efcacy of the procedure and establish a new baseline.
Key Point
The best DSA projection for imaging each vessel:
• Abdominal aorta=AP
• Internal iliac artery=contralateral oblique
• Femoral bifurcation=ipsilateral oblique
Key Point
A pressure gradient of >10 mmHg at rest or >10–
15 mmHg after nitroglycerine administration is considered a signicant stenosis and warrants treatment.
Blue Toe Syndrome
Treating patients with blue toe syndrome requires pre- procedure
imaging to identify lesions responsible for producing atherosclerotic emboli. Historically, these lesions were treated with
surgical exclusion and bypass or endarterectomy. Today, these
lesions can be successfully treated with angioplasty and stenting
much like any other vascular lesion [14, 15].
References
1. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, etal.
Comparison of global estimates of prevalence and risk factors for
peripheral artery disease in 2000 and 2010: a systematic review
and analysis. Lancet. 2013;382(9901):1329–40. https://doi.
org/10.1016/S0140-6736(13)61249-0.
2. Olin JW, White CJ, Armstrong EJ, Kadian-Dodov D,
Hiatt WR. Peripheral artery disease. J Am Coll Cardiol.
2016;67(11):1338–57. https://doi.org/10.1016/j.jacc.2015.12.049.
3. Aboyans V, Desormais I, Lacroix P. The general prognosis of
patients with peripheral arterial disease differs according to the
disease localization. J Vasc Surg. 2010;51(6):1585–6. https://doi.
org/10.1016/j.jvs.2010.04.008.
4. McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui
MH, Dolan NC, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001;286(13):1599–606. https://doi.org/10.1001/
jama.286.13.1599.
5. Abu Dabrh AM, Steffen MW, Undavalli C, Asi N, Wang Z,
Elamin MB, etal. The natural history of untreated severe or critical limb ischemia. J Vasc Surg. 2015;62(6):1642–51. https://doi.
org/10.1016/j.jvs.2015.07.065.
6. Crawford JD, Perrone KH, Wong VW, Mitchell EL, Azarbal AF,
Liem TK, Moneta GLA. Modern series of acute aortic occlusion. J Vasc Surg. 2014;59(4):1044–50. https://doi.org/10.1016/j.
jvs.2013.10.080.
7. Okazaki J, Guntani A, Homma K, Kyuragi R, Kawakubo E,
Maehara Y. Fibromuscular dysplasia of the lower extremities.
Ann Vasc Dis. 2011;4(2):143–9. https://doi.org/10.3400/avd.
cr.10.01027.
8. Chi Y.Safety and efcacy of cilostazol in the management of intermittent claudication. Vasc Health Risk Manag. 2008;4:1197–203.
https://doi.org/10.2147/vhrm.s3160.
9. Neisen M. Endovascular management of aortoiliac occlusive disease. Semin Interv Radiol. 2009;26(04):296–302. https://doi.org/1
0.1055/s-0029-1242199.
10. Jaff MR, White CJ, Hiatt WR, Fowkes GR, Dormandy J, et al. An
update on methods for revascularization and expansion of the TASC
lesion classication to include below-the-knee arteries: a supplement to the inter-society consensus for the management of peripheral
arterial disease (TASC II): the TASC Steering Committee. Catheter
Cardiovasc Interv. 2015;86(4):611–25. https://doi.org/10.1002/
ccd.26122.
11. Bosiers M, Deloose K, Callaert J, Maene L, Beelen R, Keirse K,
etal. BRAVISSIMO: 12-month results from a large scale prospective trial. JCardiovasc Surg. 2013;54(2):235–53.
12. Lee HJ, Armstrong E, Salhan N, Realyvasquez AJ, Laird JR,
Humphries M.Patency of the internal iliac artery after placement
of common and external iliac artery stents. JVasc Surg. 2015;61(6).
https://doi.org/10.1016/j.jvs.2015.04.131.
13. Aggarwal V, Waldo S, Armstrong E. Endovascular revascularization for aortoiliac atherosclerotic disease. Vasc Health
Risk Manag. 2016;12:117–27. https://doi.org/10.2147/vhrm.
s98721.
14. Renshaw A, Mccowen T, Waltke EA, Wattenhofer SP, Tahara RW,
Baxter BT.Angioplasty with stenting is effective in treating blue
toe syndrome. Vasc Endovasc Surg. 2002;36(2):155–9. https://doi.
org/10.1177/153857440203600210.
15. Matchett WJ, Mcfarland DR, Eidt JF, Moursi MM.Blue toe syndrome: treatment with intra-arterial stents and review of therapies.
JVasc Interv Radiol. 2000;11(5):585–92. https://doi.org/10.1016/
s1051-0443(07)61610-8.

Infrainguinal Disease
DylanSuttle andLukeR.Wilkins
Pathophysiology
Peripheral artery disease (PAD) describes the presence of
atherosclerotic lesions involving arteries of the upper or
lower extremities. PAD more frequently involves the lower
extremities and has a spectrum of disease patterns ranging
from asymptomatic, mild stenosis to extremely painful total
vessel occlusion, potentially resulting in limb loss. The presence of PAD dramatically increases mortality risk by related
diseases such as coronary artery disease, cerebrovascular
disease, and other major arterial diseases such as abdominal
aortic aneurysm [1]. The prevalence of PAD increases with
age after the fourth decade; 10–15% of the population in the
fth decade is affected. PAD has a slight predilection for
men over women and nonwhite ethnicity over white.
Risk factors for PAD are no different than those for atherosclerosis in general as discussed in the chapter on aortoiliac disease. Risk factors include cigarette smoking, age,
hypertension, renal insufciency, hyperlipidemia, male gender, diabetes mellitus, obesity, family history, physical inactivity, and hyperhomocysteinemia [2–6]. Smokers have four
times increased risk for developing PAD; the risk of developing PAD is proportional to the number of cigarettes smoked
[1]. Patients with diabetes mellitus are twice as likely to have
PAD; every 1% increase in hemoglobin A1c increases the
risk for PAD by 26% [7].
In order to grasp IR techniques employed in treatment of
PAD, it is important to understand the anatomic and physiologic aspects of arteries as well as the pathogenesis of athero-
D. Suttle
University of Virginia Health System, Department of Radiology
and Medical Imaging, Interventional Radiology,
Charlottesville, VA, USA
e-mail: ds8de@virginia.edu
L. R. Wilkins (
Department of Radiology and Medical Imaging,
University of Virginia Health System, Charlottesville, VA, USA
e-mail: lrw6n@virginia.edu
*)
31
sclerotic lesions. The artery wall consists of intima, media,
and adventitia [8]. The intima contains endothelial cells,
smooth muscle cells, and macrophages. The macrophages
and other immune cells play a key role in consuming circulating oxidized lipoproteins, thereby creating foam cells and
building the foundation for an atheroma, which ultimately
leads to arteriosclerosis [9]. The American Heart Association
has dened six types of atherosclerosis (Table 31.1). Only
types V and VI are detectable on angiography [6]. While
almost all PAD is caused by atherosclerosis, it is important to
be aware of other disease processes that can cause peripheral
artery narrowing or occlusion (Table31.2) [1].
As previously mentioned, PAD exists along a spectrum
from asymptomatic to life-threatening manifestations.
Symptoms typically begin with claudication and progress to
rest pain and ischemic skin lesions. The Rutherford criteria
(see Table 30.1, Chap. 30 on aortoiliac disease) delineate the
severity of lower extremity ischemia based on symptoms and
objective criteria [10].
Asymptomatic Disease (Rutherford
Category0)
The incidence of PAD is believed by some to be grossly
underestimated due to the initial asymptomatic presentation
of the disease, and the vast majority of patients with PAD are
asymptomatic. The body’s ability to grow new, collateral vessels portends an indolent, asymptomatic presentation despite
signicant arteriosclerosis. Many patients who present with
severe, acute ischemia requiring below-the-knee amputation
were asymptomatic 6months prior to presentation [11].
Claudication (Rutherford Categories 1–3)
Claudication is muscular pain in one or both legs during exercise which is relieved by rest [2, 12]. Like other manifestations
of ischemia, it results from decreased blood ow and inability
© Springer International Publishing AG, part of Springer Nature 2018
N. A. Keefe et al. (eds.), IR Playbook, https://doi.org/10.1007/978-3-319-71300-7_31
341

342
D. Suttle and L. R. Wilkins
Table 31.1 American Heart Association types of atherosclerotic
lesions [8]
Lesion type Main histology
I Isolated macrophage foam cells
II Fatty streak, mainly intracellular lipid accumulation
III Type II with small extracellular lipid pools
IV Atheroma, type II with core of extracellular lipid
V Fibroatheroma, lipid core, and brotic layer can be
VI Complicated, surface defect, thrombus
Table 31.2 Causes of peripheral artery narrowing and occlusion
Causes of peripheral artery narrowing and occlusion
Arteritis Atherosclerosis
Coarctation of the aorta Cystic adventitial disease of the popliteal
Embolic disease Fibromuscular dysplasia
Iliac artery syndrome
(cyclists)
Popliteal entrapment Primary vascular tumors
Remote arterial trauma Thrombosed popliteal artery aneurysm
calcic
Irradiation injury (usually iliac artery)
to meet the oxygen demands of the large, lower extremity
muscle groups. While claudication is the classic symptom of
lower extremity PAD, it is variable and may be present during
certain episodes of exercise and absent in others. Claudication
typically has a detrimental effect on lifestyle due to hindering
mobility. Individuals with lower extremity PAD are more
likely to have non-claudication- related, symptomatic issues,
such as arthritis, and overall increased functional disability
[13, 14].
Key Point
Claudication is dened as muscular pain in the leg during exercise that is relieved by rest. Critical limb ischemia is more severe and includes rest pain, ischemia
skin changes and acute limb ischemia.
Critical Limb Ischemia: Skin Lesions (Rutherford Categories 5–6)
Ischemic skin lesions are further on the continuum of
CLI.These typically occur on the feet and can be initiated by
a slight insult to skin integrity. Poor perfusion results in poor
healing and subsequent development of ulceration. Ischemic
ulcers may progress to frank gangrene. Beware of other
lower extremity skin lesions such as diabetic ulcers and
venous stasis ulcers in the evaluation of CLI.Diabetic ulcers
are due to neuropathy and often result from a pivotal event
such as wearing shoes that are too tight or stepping on a
sharp object. Venous stasis ulcers classically occur on the
lower leg above the medial malleolus.
Acute Limb Ischemia
Acute limb ischemia (ALI) results from sudden obstruction
of vascular ow. This can occur in a variety of settings
including atherosclerotic plaque rupture with acute thrombotic event, embolic event from a site proximal to the affected
vessel, severe vasospasm, arterial dissection, acute arterial
compression, or secondary to aneurysm thrombosis [14].
Acute embolic events are often much more profound due to
the lack of matured collateralization that typically occurs in
chronic disease associated with local thrombosis [13]. The
“six Ps” are helpful to remember the presentation of ALI:
pain, pallor, paresthesias, poikilothermia, pulselessness, and
paralysis. The latter two symptoms are late ndings indicative of severe and potentially irreversible ischemia [10].
When evaluating a patient with acute embolic ischemia, it is
prudent to consider the source of the embolus (e.g., left
atrium) to prevent further showering of emboli.
Key Point
The six Ps of acute limb ischemia:
Critical Limb Ischemia: Rest Pain (Rutherford Category 4)
Critical limb ischemia (CLI) is dened by symptoms beyond
claudication (e.g., rest pain, ischemic skin lesions, and acute
limb ischemia). Rest pain is a similar sensation as claudication but occurs in the absence of exercise. This pain often
occurs at night when the feet are in a nondependent position
with relief upon lowering the limb below the level of the
heart. Rest pain may also be described by patients as a constant, diffuse pain throughout the day with waxing and waning severity. If a patient’s initial presentation for the diagnosis
of CLI is rest pain, they have a grim prognosis of a 20%
mortality rate in 1year [1].
• Pain
• Pallor
• Paresthesias
• Poikilothermia
• Pulselessness
• Paralysis
Clinical Indication
History and physical exam are invaluable in the work-up of
lower extremity PAD. Evaluation for the risk factors
described above should certainly be obtained, as well as a

31 Infrainguinal Disease
343
detailed description of symptoms and any past surgical history should intervention be warranted. Inspection of the
patient’s skin should be focused on integrity of the skin and
presence or absence of lower extremity hair. Examining the
feet allows assessment of capillary rell time, temperature,
and pulses. The femoral, popliteal, dorsalis pedis (DP), and
posterior tibial (PT) pulses should be obtained bilaterally,
regardless of the patient’s presentation. Diagnosis by pulse
examination alone, due to inherent limitations, tends to overdiagnose PAD; therefore, more objective measurements such
as Doppler are more sensitive and can assist in stratifying
location and degree of stenosis [15].
Key Point
When evaluating a patient with PAD, evaluate the following pulses bilaterally:
• Femoral
• Popliteal
• Dorsalis pedis (DP)
• Posterior tibial (PT)
Pulses can be absent, monophasic, biphasic, or triphasic (normal) based on the waveform. They are
graded on intensity from 0 (absent) to 4+ (bounding).
There are two inexpensive non-imaging-based tests which
are used for the initial evaluation of most lower extremity
PAD. Ankle-brachial index (ABI) objecties the presence
and degree of lower extremity drop in blood pressure
(Table31.3, Fig.31.1) [16]. ABI is simply a ratio of the highest systolic pressure obtained from the ankle (either DP or
PT) of the affected leg to the highest systolic pressure of
either arm. ABI should be obtained for each lower extremity.
ABIs are typically calculated with a sphygmomanometer
and Doppler, but if a Doppler is unavailable, a stethoscope
over the artery of interest has proven accurate in the initial
work-up [17]. The presence of PAD is a marker of diffuse
vascular disease: in general, the lower the ABI, the greater
the risk of a cardiovascular event [2]. In patients with diabetes mellitus or otherwise non-compressible arteries, toebrachial index may be used and follows the same concept as
ABI but is performed with a miniature sphygmomanometer
Table 31.3 Interpreting ankle-brachial index (ABI)
Result Interpretation
>1.30 Non-compressible (diabetes mellitus, calcic medial
sclerosis)
0.91–1.30 Normal
0.41–0.90 Mild to moderate PAD, claudication
0.00–0.40 Severe PAD, rest pain
for the big toe. Toe systolic pressure is typically greater than
50 mm Hg. Patients with a toe systolic pressure less than
30mm Hg typically are unable to heal lower extremity ulcers
or surgical incisions [13]. Exercise testing is another method
of ABI calculation by which the patient exercises for 5min
or until the pain is reproduced, at which time the ABI is calculated. A decrease in ABI by 15–20% during exercise is
diagnostic for PAD [1].
Pulse volume recordings measure the global perfusion of
an extremity. Multiple cuffs are applied and inated at low
pressure in sequence along an extremity. Subtle changes in
pressure in the cuff with each heart beat are graphed. Changes
in waveform indicate decreased perfusion and can reveal the
general location of an occlusion [13].
Imaging studies provide assessment of the degree of vascular calcication, the precise location and size of lesions,
targets for revascularization, and localization of collateral
vessels. Cross-sectional imaging (e.g., ultrasound, CTA, and
MRA) have largely replaced angiography as a primary imaging choice for workup and diagnosis.
Duplex ultrasound determines morphology of a lesion
and calculates blood ow velocities and turbulence within a
vessel (Fig.31.2). Increasing ow velocity indicates a higher
degree of stenosis until the narrowing becomes so severe that
ow is nearly obstructed. It is particularly useful in monitoring patency of bypass grafts. Computed tomography angiography (CTA) provides a timely assessment and mapping of
lower extremity arteries (Fig.31.3). It requires the use of
intravenous iodinated contrast, which may be contraindicated in patients with renal failure. Additionally, it subjects
the patient to ionizing radiation exposure. Magnetic resonance angiography (MRA) is highly sensitive for the evaluation of luminal stenosis (Fig.31.4). Intravenous gadolinium
is typically used. It is possible to obtain MRA without gadolinium, but this requires much longer image acquisition
sequences termed time of ight, which some patients may
not be able to tolerate. MRA is the most expensive of these
imaging studies and may not be as widely available as CTA
or ultrasound [13].
Angiography has evolved into a secondary imaging
choice for evaluation of lower extremity arterial stenosis.
Most patients undergoing angiography have had noninvasive
imaging workup prior to arriving in the uoroscopy suite.
Typically, the right femoral artery is accessed using the
Seldinger technique. An abdominal aortogram is performed
rst to evaluate for concomitant visceral and subsequently
iliac and pelvic occlusive disease. Attention is then turned to
the lower extremities, and time-delayed exposures after
bolus contrast injections are performed to evaluate the entire
lower extremity. Manipulations of the patient’s leg position
and angle of the C-arm are employed to provide optimal
visualization of all the extremity arterial branches. The

344
Fig. 31.1 Ankle brachial
index. ABIs of a 53-year-old
male with left leg
claudication. (a) Pre-stent
placement ABI.Notice the
right leg has biphasic
waveforms and an ABI of
0.92, while the left leg has
monophasic waveforms and
ABI of 0.41, indicating
moderate PAD. (b) Status
post left SFA stent placement
the left ABI returns to normal
D. Suttle and L. R. Wilkins
Соседние файлы в папке Библиотека им академика М.И. Перельмана
